TY - JOUR
T1 - Growth factor induction of cripto-1 shedding by glycosylphosphatidylinositol-phospholipase D and enhancement of endothelial cell migration
AU - Watanabe, Kazuhide
AU - Bianco, Caterina
AU - Strizzi, Luigi
AU - Hamada, Shin
AU - Mancino, Mario
AU - Bailly, Veronique
AU - Mo, Wenjun
AU - Wen, Dingyi
AU - Miatkowski, Konrad
AU - Gonzales, Monica
AU - Sanicola, Michele
AU - Seno, Masaharu
AU - Salomon, David S.
PY - 2007/10/26
Y1 - 2007/10/26
N2 - Cripto-1 (CR-1) is a glycosylphosphatidylinositol (GPI)-anchored membrane glycoprotein that has been shown to play an important role in embryogenesis and cellular transformation. CR-1 is reported to function as a membrane-bound co-receptor and as a soluble ligand. Although a number of studies implicate the role of CR-1 as a soluble ligand in tumor progression, it is unclear how transition from the membrane-bound to the soluble form is physiologically regulated and whether differences in biological activity exist between these forms. Here, we demonstrate that CR-1 protein is secreted from tumor cells into the conditioned medium after treatment with serum, epidermal growth factor, or lysophosphatidic acid, and this soluble form of CR-1 exhibits the ability to promote endothelial cell migration as a paracrine chemoattractant. On the other hand, membrane-bound CR-1 can stimulate endothelial cell sprouting through direct cell-cell interaction. Shedding of CR-1 occurs at the GPI-anchorage site by the activity of GPI-phospholipase D (GPI-PLD), because CR-1 shedding was suppressed by siRNA knockdown of GPI-PLD and enhanced by overexpression of GPI-PLD. These findings describe a novel molecular mechanism of CR-1 shedding, which may contribute to endothelial cell migration and possibly tumor angiogenesis.
AB - Cripto-1 (CR-1) is a glycosylphosphatidylinositol (GPI)-anchored membrane glycoprotein that has been shown to play an important role in embryogenesis and cellular transformation. CR-1 is reported to function as a membrane-bound co-receptor and as a soluble ligand. Although a number of studies implicate the role of CR-1 as a soluble ligand in tumor progression, it is unclear how transition from the membrane-bound to the soluble form is physiologically regulated and whether differences in biological activity exist between these forms. Here, we demonstrate that CR-1 protein is secreted from tumor cells into the conditioned medium after treatment with serum, epidermal growth factor, or lysophosphatidic acid, and this soluble form of CR-1 exhibits the ability to promote endothelial cell migration as a paracrine chemoattractant. On the other hand, membrane-bound CR-1 can stimulate endothelial cell sprouting through direct cell-cell interaction. Shedding of CR-1 occurs at the GPI-anchorage site by the activity of GPI-phospholipase D (GPI-PLD), because CR-1 shedding was suppressed by siRNA knockdown of GPI-PLD and enhanced by overexpression of GPI-PLD. These findings describe a novel molecular mechanism of CR-1 shedding, which may contribute to endothelial cell migration and possibly tumor angiogenesis.
UR - http://www.scopus.com/inward/record.url?scp=35748957808&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=35748957808&partnerID=8YFLogxK
U2 - 10.1074/jbc.M702713200
DO - 10.1074/jbc.M702713200
M3 - Article
C2 - 17720976
AN - SCOPUS:35748957808
SN - 0021-9258
VL - 282
SP - 31643
EP - 31655
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 43
ER -